论文部分内容阅读
目的讨论并分析中晚期肺癌患者采用艾迪注射液联合放化疗进行治疗的临床效果。方法 80例中晚期肺癌患者,随机分为观察组和对照组,各40例。对照组行单纯放化疗,观察组在对照组的基础上加入艾迪注射液联合治疗。术后随访就两组患者的治疗效果、用药副作用及3个月生存率和治疗后生活质量评分(KPS)等情况进行比较。结果两组患者的治疗有效率、白细胞减少、腹泻、恶心呕吐、外周神经毒性、3个月生存率和治疗后KPS比较,差异均有统计学意义(P<0.05)。结论在中晚期肺癌患者的临床治疗中,采用艾迪注射液联合放化疗的治疗方法 ,不仅能有效提高患者的治疗效果,还能降低患者的用药副作用,综合效果优于单纯放化疗治疗,具有较高的临床价值,方法值得借鉴。
Objective To discuss and analyze the clinical effect of using Aidi injection combined with radiochemotherapy in patients with advanced lung cancer. Methods 80 patients with advanced lung cancer were randomly divided into observation group and control group, 40 cases in each. The control group received radiotherapy and chemotherapy alone. The observation group was given Aidi Injection on the basis of the control group. The follow-up results were compared between the two groups in terms of the therapeutic effect, side effects of medication, 3-month survival rate and post-treatment quality of life score (KPS). Results The therapeutic efficiency, leukopenia, diarrhea, nausea and vomiting, peripheral neurotoxicity, 3-month survival rate and KPS after treatment in both groups were significantly different (P <0.05). Conclusion In the clinical treatment of patients with advanced lung cancer, Aidi injection combined with radiotherapy and chemotherapy treatment can not only effectively improve the therapeutic effect of patients, but also reduce the side effects of the drug in patients, the overall effect is better than the simple radiotherapy and chemotherapy, with Higher clinical value, the method is worth learning.